Paluray, Remegio S.

HRN: 22-17-67  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2022
CEFTRIAXONE 1G (VIAL)
11/07/2022
11/16/2022
IVT
2 G
Once A Day
Community Acquired Pneumonia
Waiting Final Action 
11/07/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/07/2022
11/16/2022
IVT
600 Mg
Q6
Community Acquired Pneumonia,
Waiting Final Action 
11/15/2022
CEFTRIAXONE 1G (VIAL)
11/15/2022
11/21/2022
IVT
2g
OD X 3 Days More
Alcoholic Liver Disease
11/15/2022
CEFTRIAXONE 1G (VIAL)
11/15/2022
11/17/2022
IVT
2g
Od X 3 Days More
Alcoholic Liver Disease
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: